TCL Archive Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival December 28, 2012
TCL Archive Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices September 3, 1993